Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combined With Chemical Ablation in the Treatment of Uterine Fibroids: A Prospective, Multicenter Study

NCT07754877 is registered in ClinicalTrials.gov with Peking University Aerospace Center Hospital as lead sponsor.

NCT NCT07754877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07754877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combined With Chemical Ablation in the Treatment of Uterine Fibroids: A Prospective, Multicenter Study
Lead sponsor
Peking University Aerospace Center Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
August 30, 2028
Enrollment
248 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microwave ablation, ultrasound, uterine fibroids (uf)